Evidence map›Paper›PMID 21108811›Full record

ArticleNutrition & metabolism2010

Fresh raspberry phytochemical extract inhibits hepatic lesion in a Wistar rat model.

Yan Liu, Ming Liu, Bin Li, Jin-Lu Zhao, Chun-Peng Zhang, Luo-Qiang Lin, Hong-Sheng Chen, Shu-Jun Zhang, Jun-Chao Jin, Lei Wang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nutrition & metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. The Effective Analysis for Blue Honeysuckle Extract in the Treatment of Hepatocellular Carcinoma.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Yan Liu *Treatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Ming Liu *Treatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Bin Li *Treatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Jin-Lu ZhaoTreatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Chun-Peng ZhangTreatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Luo-Qiang LinTreatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Hong-Sheng ChenTreatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Shu-Jun ZhangTreatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Jun-Chao JinTreatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Lei WangTreatment Center of Oncology, the Fourth Affiliated Hospital of Harbin Medical University, 37 YiYuan Street, NanGang District, Harbin, 150001, The People's Republic of China.
Le-Jing LiThe Affiliated Tumor Hospital of Harbin Medical University, 6 BaoJian Road, NanGang District, Harbin, 150086, The People's Republic of China.
Jia-Ren LiuPublic Health College, Harbin Medical University, 157 BaoJian Road, NanGang District, Harbin, 150081, The People's Republic of China.
Harbin Medical University · CNFourth Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRed raspberry possesses potent antioxidant capacity and antiproliferative activity against cancer in vitro.

methodsThe objective of this study was to determine the protective effects of raspberry 80% acetone extract in a rat hepatic lesions model induced by diethylnitrosamine (DEN). Rats were treated with the red raspberry extract (0.75, 1.5 or 3.0 g/kg of body weight) by gavage starting 2 h after DEN administration and continuing for 20 weeks.

resultsA dose-dependent inhibition by red raspberry extract of DEN-induced hepatic nodule formation which stands for hepatic lesions was observed. Corresponding hepatic nodule incidence rates were 45.0, 40.0, 25.0 and 5.0% in positive control, low, middle and high groups, respectively (P < 0.01 or 0.05). Gross findings, histopathological and ultrastructural evaluations of hepatic lesion were performed on 9, 8, 5 and 1 hepatic nodule in positive control, low, middle and high doses of groups, respectively, identified in rats from the respective groups of 20. A decreasing trend of proportions of hepatocellular carcinoma masses accompanied the increasing doses of red raspberry extract.

conclusionsThese findings demonstrate that the potent capacity of red raspberry diet could not only suppress DEN-induced hepatic lesions in rats, but also reduce the definite diagnostic features of neoplasm.

Identifiers

PMID21108811
PMCPMC2999596
OpenAlexW2099324363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.